AWS Finance teams used Amazon Quick's chat agents and Flows to automate two time-consuming workflows: scenario modeling for strategic customers and weekly business reviews, reducing analysis time from hours to minutes and enabling teams to focus on strategic partnership.

Google Research conducted a large-scale real-world study in 10 US cities showing that slightly rerouting a small fraction of trips (under 2%) using navigation apps can measurably reduce traffic congestion and emissions. The study, published in Nature Cities, found median speed increases of 2% on targeted segments and potential CO2e savings of thousands of tons per city per year.

LLMIntel is a demo dashboard for monitoring GenAI model usage costs, endpoint health, and optimization opportunities. It provides views for model status, cost analysis, usage trends, at-risk spend, and tag breakdowns, helping teams take action before model deprecation or cost spikes.

This article argues that multi-agent orchestration, not larger context windows, is the real breakthrough for handling long-context problems. INT21's SwarmOS platform demonstrates effective context scaling by decomposing tasks into coordinated smaller agents.

A new method called Antidoom uses Final Token Preference Optimization (FTPO) to precisely target and eliminate repetitive loops (doom loops) in language models, achieving near-complete elimination on multiple models with improved eval scores.

This article explores how AI advancements could enable autonomous robots to work in workplaces and homes, featuring insights from researchers like Dipam Patel and highlighting challenges such as catastrophic forgetting and the need for self-contained robots.

An experimental Web Component built with GPT-5.5 that embeds code from GitHub by converting blob URLs to raw content URLs and fetching specified line ranges. Displays line numbers without syntax highlighting.

Same three analytics problems, three tools, eight dimensions, measured with real execution times and real agent prompts.

Anthropic is bringing Claude Cowork to web and mobile, with usage data revealing over 90% of sessions are unrelated to software development. The feature, described as 'the work around the work,' focuses on automating administrative tasks. It now supports cloud-based scheduling, mobile notifications, and is in beta for Max subscribers.

Anthropic moves Claude Cowork to the cloud, enabling tasks to continue offline and across devices. Max plan subscribers get beta access now, with broader rollout in weeks. Chat and Cowork share a unified interface, and scheduled tasks now run in the cloud automatically.

A CLI tool for your coding agent to ship agents.

Researchers have documented a ransomware campaign that appears to be entirely AI-driven. Known as JadePuffer, it may be the first known case of an AI agent orchestrating a full attack chain. The case underscores the urgency with which organizations must defend themselves using AI-powered security solutions.

Miora is an AI-powered creative platform that provides an editable canvas with agent memory, enabling users to scale their creativity.

DoodleMeme is a tool that animates children's drawings without generative AI, using traditional character rigging and motion retargeting. It's free, no login required, and works on mobile and desktop.

This article explores why over 80% of enterprise AI projects fail, identifying fragmented data and lack of unified context as primary barriers. Insights from Arango and IBM experts highlight four key areas for building explainable, trustworthy agentic AI systems.

sqlite-utils 4.0 is released with database schema migrations. It is a Python CLI utility and library for manipulating SQLite databases.

This article categorizes AI safety risks through the lens of intentions into four types: good human intentions with unreliable systems, bad human intentions turning AI into a war machine, good AI intentions with ambiguous use cases, and bad AI intentions leading to alignment hell. It discusses examples, mitigation strategies, and the need for technical, institutional, and policy approaches.

Atrophy is a command-line app that regularly gives you small coding exercises to solve without AI help, grades your solution, maintains a skill rating (like chess Elo), and charts changes over time. It covers five skills (syntax recall, debugging, code reading, API memory, decomposition), supports Python and JavaScript, adapts difficulty, and provides a comparison chart between unaided and AI-assisted performance.

SOCBench is an open benchmark that evaluates frontier reasoning LLMs as SOC agents on raw NetFlow data. It provides a multi-turn agent loop with persona-scoped tools, multiple provider adapters, and scoring lenses. The repository is local-first and requires only a laptop, three API keys, and a sample parquet to reproduce. It is currently in alpha with a full end-to-end pipeline.

TraceGen is a single-binary trace generator that produces realistic, topology-rich OTLP traces and correlated logs, simulating a full e-commerce platform with up to 28 services and 40 scenario flows including AI agentic patterns. It requires no infrastructure setup – just one executable. Built for testing observability platforms and showcasing distributed system visualizations, it supports traditional APM and LLM observability in a unified tool.

How LangChain mines agent traces to find failures, fine-tune judge models cheaper than frontier LLMs, and hill-climb performance with evals.

Max single-threaded CPUs at scale are a new category of CPUs built for the agentic AI era. Across the creation and deployment of an agentic system, the CPU is on the critical path for reasoning, response time and learning. CPUs are the processor which executes the work the AI model commands: the tool calling, code execution, data processing, KV-cache and result analysis.

Schneider Electric built enterprise LLMOps foundations with LangSmith to improve observability, evaluation, and deployment for AI products at scale. Their AI Hub of 350 experts deployed 60+ agents. The three pillars: self-hosted LangSmith for observability, offline/online evaluation with maturity framework, and per-product deployment. Case studies include internal AI assistant One Jo, CSM Copilot, and document processing agent, showing significant efficiency gains.

The professor of physics and inaugural director of the NSF AI Institute for Artificial Intelligence and Fundamental Interactions will lead LNS and continue his research in particle physics.

Bloomiro is an SEO and AI search visibility platform for SaaS teams, tracking rankings, AI mentions, citations, competitors, and tasks that move visibility forward, with MCP integrations for developer tools like Cursor and Claude Code.

APIs transform advanced AI capabilities into accessible interfaces, allowing a single developer to build complex applications. An experiment controlling a computer by voice demonstrates how APIs reduce months of research to an afternoon of integration.

The move marks the chipmaker’s first foray into autonomous vehicle technology.

Insilico Medicine is advancing to Phase III human trials for testing a drug identified by AI targeting idiopathic pulmonary fibrosis (IPF). This progression supplies the computational drug discovery sector with empirical test cases, advancing an AI medicine past early safety evaluations into late-stage efficacy validation. IPF destroys respiratory capacity through severe lung tissue scarring. Patients typically present a median survival rate reaching two to four years post-diagnosis. The AI-identified drug, rentosertib, inhibits the TRAF2- and NCK-interacting kinase to address underlying disease mechanisms when administered orally. A randomised trial evaluated 71 patients across 22 Chinese clinical sites, separating participants into placebo and active treatment cohorts. Investigators administered 30 mg or 60 mg daily doses over a 12-week observation window. Patients assigned to the 60 mg once-daily regimen demonstrated a mean forced vital capacity gain of +98.4 mL, contrasting sharply with the 20.3 mL capacity loss recorded in the placebo group. Safety profiles remained manageable, with adverse events mirroring expected baseline rates across all trial arms. Regulatory authorities at the U.S. Food and Drug Administration (FDA) granted ‘Orphan Drug Designation’ to the asset in February 2023. Algorithmic target prioritisation through multi-omics. The development relies entirely on Pharma.AI, the proprietary computational pipeline operating at Insilico Medicine. The workflow segments into distinct engines handling specific biological and chemical engineering tasks. PandaOmics executes the initial target discovery phase. The system ingests vast biological datasets, processing genomics, clinical trial outcomes, academic literature, and patent intelligence to construct comprehensive biological network models. The algorithms apply causal inference mechanisms to identify novel disease links hidden within the data architecture. PandaOmics isolated TNIK as the primary biological target regarding IPF intervention. The computational system bypassed the receptor tyrosine kinase pathways targeted by existing antifibrotic medications. The software mapped TNIK as a central node regulating fibrosis and inflammation via Wnt, TGF-β, Hippo/YAP-TAZ, JNK, and NF-κB signalling channels. The target selection process integrated a hallmarks-of-aging framework, scoring biological targets based on their implication in multiple aging mechanisms, chronic inflammation, and extracellular matrix remodelling. Feng Ren, PhD, Co-CEO and Chief Scientific Officer of Insilico Medicine, said: “IPF is one of the clearest clinical examples of an age-related disease in which fibrosis, chronic inflammation, extracellular matrix remodeling, and cellular senescence intersect. “Rentosertib was not discovered by starting from a conventional target and simply screening more compounds. It came from a biology-first, ageing-informed AI workflow that connected TNIK to fibrotic and inflammatory disease mechanisms, and then used generative chemistry to create a drug candidate with the properties required for clinical development.” Generative molecular engineering execution. Following target selection, the Chemistry42 engine executes generative molecular design. The system departs from traditional high-throughput screening methodologies. Chemistry42 does not search existing compound libraries—instead, the system applies Generative Tensorial Reinforcement Learning to build molecules that physically align with the target protein pocket. This algorithmic engineering process balances structural fit against required pharmacological properties. The computational generation phase synthesised exactly 79 physical molecules to undergo testing. The engineering team selected the 55th iteration to advance into preclinical testing. This targeted generation protocol reduced the timeline from project initiation to preclinical candidate nomination to 18 months. The foundational architecture stems from the 2019 publication of the company’s GENTRL methodology in Nature Biotechnology. The platform establishes reproducible systems regulating molecular generation, avoiding the capital-intensive trial-and-error processes defining standard pharmaceutical chemistry. Validating biological impact through proteomic analysis. Clinical assessment integrates complex proteomic analysis to validate the algorithmically-predicted biological interactions. Insilico Medicine deploys internal proteomic aging-clock frameworks within the IPF trial to capture exploratory geroscience readouts. Chronological-age proteomic clocks – including ProtAge, OrganAgechrono, ipfP3GPT, and PAOPAC – track predicted biological-age changes resulting from the intervention. Researchers apply UK Biobank age-associated trajectories as external comparison datasets, contextualising treatment-responsive proteins against broad population data. Mortality-risk-related proteomic clocks, including PAC and OrganAgemortality, provide orthogonal analytical streams alongside standard clinical endpoints. The clinical teams execute SenMayo and CellAge signature analyses to evaluate senescence and senescence-associated secretory phenotype biology within cellular models. Peer-reviewed research published in Aging and Disease confirmed that pharmacological TNIK inhibition produces senomorphic activity, generating observable reductions in extracellular matrix remodelling indicators. Documenting the computational pipeline. The transition of rentosertib through the clinical pipeline provides a documented, peer-reviewed data trail essential to verifying AI capabilities in life sciences. Nature Biotechnology published the complete discovery-to-clinic progression. The publication details the algorithmic TNIK target prioritisation, the generative chemistry outputs, preclinical efficacy data, and human Phase I pharmacokinetics. The Journal of Medicinal Chemistry published the structural biology validation, detailing the discovery of the novel TNIK inhibitor chemotypes and supplying structural backing via the TNIK kinase domain co-crystal structure. Nature Medicine documented the Phase IIa safety and lung-function data, providing empirical validation of the computational predictions. Alex Zhavoronkov, PhD, Founder and CEO of Insilico Medicine, commented: “Rentosertib is a defining program for Insilico because it represents the full arc of our mission: using AI not only to move faster, but to originate new biology, new chemistry, and new therapeutic opportunities. “This program began with the hypothesis that ageing biology could help identify powerful targets for major diseases. It has now advanced through target discovery, molecular design, preclinical validation, Phase I safety, randomised Phase IIa clinical data, and into Phase III development. For the AI drug discovery field, this is no longer only a speed story—it is a clinical translation story.” Adoption of AI in biopharma requires verifiable data regarding human outcomes. The Phase III trial subjects the generative algorithms to the definitive test of clinical efficacy.

This article introduces a method to render PDF pages as images and use Google DeepMind's Gemma 4 vision-language model for local document parsing. The approach unifies scanned and digital PDFs, eliminating the need for OCR or layout parsers, with flexible visual token budgets and complete code examples.

An anonymous artist exposed bias against AI art by revealing a real Monet painting. Despite controversy, the AI art market is forming, encompassing NFTs and physical installations. A collector spent $72,000 on early AI works. Refik Anadol opened Dataland, the first generative AI museum in Los Angeles. Market data shows digital art sales nearly tripled from 2024 to 2025, but Christie's closed its digital art department. A stock image platform saw an 80% sales jump after allowing AI images. Experts distinguish prompt-generated images from true AI art, which requires deep engagement.